focus -WSS

focus

author：entertainment 2025-09-28 22:28:46 - browse：64

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Vertex Pharmaceuticals may move headquarters in Boston

focus

WSS

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Bird flu makes raw milk dangerous to consume, mouse study finds

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Oprah kicked off a national conversation on obesity. Let's have it

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Stroke rates rising, especially in working

knowledge

focus

knowledge

Peter Hotez and the public health issue of online harassment

The Readout: Lenmeldy, GLP

Apple is now the first public company to be valued at $3 trillion

Patient advocates debate FDA's accelerated approval process

Hollywood unions extend contract negotiations for actors

Guardant Health colon cancer test endorsed by FDA advisory panel

Peter Hotez and the public health issue of online harassment

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

United colonoscopy coverage change 'may cost lives,' doctors say

Should insurance cover cosmetic surgery?

focus

Lawsuit challenges CMS nursing home minimum staffing rule

Beyond aggravation: Constipation is an American epidemic

Patient advocates debate FDA's accelerated approval process

Abortion pill case raises question: who can sue the FDA?

Some medical students still think black patients feel less pain

States should stop sabotaging methadone treatment reform

focus

knowledge

knowledge

Wikipedia